度他雄胺在真实临床实践中治疗额部纤维性脱发的疗效
这项回顾性观察研究纳入224例额部纤维性脱发(FFA)患者,随访至少12个月,评估度他雄胺与其他系统治疗或无系统治疗相比对发际线后退稳定化的疗效。结果显示度他雄胺组12个月时额部、右颞和左颞的稳定率分别为62%、64%和62%,显著优于无系统治疗组,且稳定率与度他雄胺剂量增加呈显著相关(每周5或7次0.5mg时达88%、91%、84%),耐受性良好。
要点
- 度他雄胺是FFA真实临床实践中最有效的系统治疗,且呈剂量依赖性反应。
- 12个月时度他雄胺组额部、右颞、左颞稳定率分别为62%、64%、62%。
- 每周5或7次0.5mg度他雄胺时稳定率可达88%、91%、84%。
核心结论
- 口服度他雄胺是真实临床实践中治疗FFA最有效的系统治疗,且呈剂量依赖性反应。
研究设计与样本
- 回顾性观察研究,纳入224例FFA患者(222例女性),中位随访24个月(范围12-108个月)。
主要发现
- 度他雄胺组(n=148)12个月时额部、右颞、左颞稳定率分别为62%、64%、62%。
- 其他系统治疗组(n=20)对应稳定率分别为60%、35%、35%。
- 无系统治疗组(n=56)对应稳定率分别为30%、41%、38%,与度他雄胺组比较P值分别为.000、.006、.006。
- 每周5或7次0.5mg度他雄胺时(n=32)稳定率达88%、91%、84%,与剂量增加显著相关(P < .005)。
- 度他雄胺在所有患者中耐受性良好。
关键数值与推荐
- 疗效评估依据发际线后退的稳定化。
- 稳定率与度他雄胺剂量增加呈统计学显著关联(P < .005)。
临床怎么用
- 真实临床实践中可考虑口服度他雄胺治疗FFA,并可根据耐受性评估增加剂量以提高稳定率。
局限性
- 研究为观察性、回顾性设计。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Dutasteride has been proposed as an effective therapy for frontal fibrosing alopecia (FFA). OBJECTIVES: We sought to describe the therapeutic response to dutasteride and the most effective dosage in FFA compared with other therapeutic options or no treatment. METHODS: This was a retrospective observational study including patients with FFA with a minimum follow-up of 12 months. Therapeutic response was evaluated according to the stabilization of the hairline recession. RESULTS: A total of 224 patients (222 females) with a median follow-up of 24 months (range 12-108 months) were included. The stabilization rate for the frontal, right, and left temporal regions after 12 months was 62%, 64%, and 62% in the dutasteride group (n = 148), 60%, 35%, and 35% with other systemic therapies (n = 20), and 30%, 41%, and 38% without systemic treatment (n = 56; P = .000, .006, and .006, respectively). Stabilization showed a statistically significant association with an increasing dose of dutasteride (88%, 91%, and 84% with a weekly treatment of 5 or 7 doses of 0.5 mg [n = 32], P < .005). Dutasteride was well tolerated in all patients. LIMITATIONS: Limitations included the observational and retrospective design. CONCLUSIONS: Oral dutasteride was the most effective therapy with a dose-dependent response for FFA in real clinical practice compared with other systemic therapies or no systemic treatment.
引用
- Pindado-Ortega C, Saceda-Corralo D, Moreno-Arrones ÓM, et al. Effectiveness of dutasteride in a large series of patients with frontal fibrosing alopecia in real clinical practice. J Am Acad Dermatol. 2020. PMID: 33038469. doi:10.1016/j.jaad.2020.09.093
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。